Neuland Laboratories Ltd. | Mid-cap | Healthcare
₹11,962.00
-0.49%
| Neuland Laboratories Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 14.8B
Gross Profit 7.3B 49.18%
Operating Income 2.6B 17.45%
Net Income 2.6B 17.61%
EPS (Diluted) ₹202.74

Balance Sheet Metrics

Total Assets 21.8B
Total Liabilities 6.6B
Shareholders Equity 15.2B
Debt to Equity 0.43

Cash Flow Metrics

Operating Cash Flow 3.4B
Free Cash Flow 1.1B

Revenue & Profitability Trend

Neuland Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 14.8B 15.2B 11.6B 9.2B 9.2B
Cost of Goods Sold 7.5B 7.3B 6.1B 5.5B 5.5B
Gross Profit 7.3B 7.8B 5.5B 3.7B 3.6B
Operating Expenses 1.3B 973.2M 866.0M 692.1M 818.8M
Operating Income 2.6B 4.1B 2.3B 960.9M 1.1B
Pre-tax Income 3.5B 4.0B 2.2B 821.6M 1.1B
Income Tax 862.2M 1.0B 522.3M 183.4M 247.0M
Net Income 2.6B 3.0B 1.6B 638.2M 806.3M
EPS (Diluted) ₹202.74 ₹233.89 ₹127.45 ₹49.74 ₹62.85

Income Statement Trend

Neuland Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 11.4B 9.2B 7.6B 5.8B 5.5B
Non-Current Assets 10.4B 9.1B 8.2B 8.0B 7.8B
Total Assets 21.8B 18.3B 15.8B 13.8B 13.2B
Liabilities
Current Liabilities 4.7B 4.3B 4.4B 3.6B 3.7B
Non-Current Liabilities 1.9B 1.2B 1.5B 1.8B 1.7B
Total Liabilities 6.6B 5.5B 5.9B 5.4B 5.4B
Equity
Total Shareholders Equity 15.2B 12.8B 9.9B 8.4B 7.9B

Balance Sheet Composition

Neuland Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 3.5B 4.0B 2.2B 821.6M 1.1B
Operating Cash Flow 3.4B 3.0B 1.6B 667.9M 1.3B
Investing Activities
Capital Expenditures -2.1B -1.4B -646.4M -972.5M -1.1B
Investing Cash Flow -4.0B -1.6B -630.4M -955.9M -677.6M
Financing Activities
Dividends Paid -179.6M -128.3M -64.1M -38.5M -25.7M
Financing Cash Flow 373.8M -634.3M -2.0B 538.1M -2.0B
Free Cash Flow 1.1B 1.2B 1.7B -373.0M 839.6M

Cash Flow Trend

Neuland Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 60.56
Forward P/E 31.55
Price to Book 10.35
Price to Sales 10.68
PEG Ratio -4.55

Profitability Ratios

Profit Margin 17.61%
Operating Margin 10.41%
Return on Equity 18.53%
Return on Assets 8.03%

Financial Health

Current Ratio 2.45
Debt to Equity 10.31
Beta 0.22

Per Share Data

EPS (TTM) ₹203.08
Book Value per Share ₹1,188.33
Revenue per Share ₹1,151.11

Financial data is updated regularly. All figures are in the company's reporting currency.